Parametric Portfolio Associates’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-51,296
| Closed | -$482K | – | 4061 |
|
|
2020
Q3 | $482K | Buy |
51,296
+8,236
| +19% | +$78.3K | ﹤0.01% | 3299 |
|
|
2020
Q2 | $329K | Buy |
43,060
+2,231
| +5% | +$17.1K | ﹤0.01% | 3440 |
|
|
2020
Q1 | $252K | Sell |
40,829
-57,417
| -58% | -$506K | ﹤0.01% | 3456 |
|
|
2019
Q4 | $1.2M | Sell |
98,246
-32,129
| -25% | -$351K | ﹤0.01% | 2968 |
|
|
2019
Q3 | $1.51M | Buy |
130,375
+5,000
| +4% | +$52.6K | ﹤0.01% | 2805 |
|
|
2019
Q2 | $1.25M | Sell |
125,375
-35,923
| -22% | -$388K | ﹤0.01% | 2941 |
|
|
2019
Q1 | $2.08M | Sell |
161,298
-34,619
| -18% | -$516K | ﹤0.01% | 2638 |
|
|
2018
Q4 | $2.98M | Sell |
195,917
-121,031
| -38% | -$2.31M | ﹤0.01% | 2305 |
|
|
2018
Q3 | $6.34M | Sell |
316,948
-157,027
| -33% | -$3.57M | 0.01% | 1824 |
|
|
2018
Q2 | $9.24M | Buy |
473,975
+48,271
| +11% | +$1.07M | 0.01% | 1431 |
|
|
2018
Q1 | $8.58M | Buy |
425,704
+63,898
| +18% | +$1.08M | 0.01% | 1461 |
|
|
2017
Q4 | $4.79M | Buy |
361,806
+77,415
| +27% | +$1.17M | ﹤0.01% | 1954 |
|
|
2017
Q3 | $5.25M | Sell |
284,391
-798
| -0.3% | -$14.9K | 0.01% | 1796 |
|
|
2017
Q2 | $5.25M | Buy |
285,189
+40,490
| +17% | +$802K | 0.01% | 1731 |
|
|
2017
Q1 | $5.52M | Sell |
244,699
-26,723
| -10% | -$640K | 0.01% | 1663 |
|
|
2016
Q4 | $9.45M | Sell |
271,422
-11,865
| -4% | -$354K | 0.01% | 1080 |
|
|
2016
Q3 | $6.94M | Sell |
283,287
-672
| -0.2% | -$16.8K | 0.01% | 1256 |
|
|
2016
Q2 | $6.79M | Buy |
283,959
+138,928
| +96% | +$3.19M | 0.01% | 1244 |
|
|
2016
Q1 | $3.39M | Buy |
145,031
+97,639
| +206% | +$2.32M | 0.01% | 1957 |
|
|
2015
Q4 | $1.43M | Buy |
47,392
+6,193
| +15% | +$200K | ﹤0.01% | 2498 |
|
|
2015
Q3 | $1.64M | Buy |
41,199
+3,865
| +10% | +$240K | ﹤0.01% | 1987 |
|
|
2015
Q2 | $2.58M | Buy |
37,334
+5,204
| +16% | +$327K | 0.01% | 2020 |
|
|
2015
Q1 | $1.76M | Sell |
32,130
-1,941
| -6% | -$92.5K | ﹤0.01% | 2355 |
|
|
2014
Q4 | $1.45M | Sell |
34,071
-7,677
| -18% | -$277K | ﹤0.01% | 2453 |
|
|
2014
Q3 | $1.33M | Buy |
41,748
+8,306
| +25% | +$177K | ﹤0.01% | 2445 |
|
|
2014
Q2 | $693K | Buy |
33,442
+608
| +2% | +$11.2K | ﹤0.01% | 2997 |
|
|
2014
Q1 | $635K | Buy |
32,834
+4,170
| +15% | +$88.6K | ﹤0.01% | 3029 |
|
|
2013
Q4 | $696K | Buy |
28,664
+7,286
| +34% | +$171K | ﹤0.01% | 2930 |
|
|
2013
Q3 | $459K | Buy |
21,378
+5,877
| +38% | +$139K | ﹤0.01% | 3151 |
|
|
2013
Q2 | $345K | Buy |
+15,501
| New | +$342K | ﹤0.01% | 3218 |
|
Parametric Portfolio Associates's AMAG Position: Q4 2020 in Review
Parametric Portfolio Associates sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 51,296 shares — an estimated $482K sold.
Parametric Portfolio Associates first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $9.45M in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Parametric Portfolio Associates reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Parametric Portfolio Associates sold 51,296 AMAG Pharmaceuticals shares in Q4 2020, an estimated $482K.
- Parametric Portfolio Associates first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Parametric Portfolio Associates's AMAG Pharmaceuticals position peaked at $9.45M in Q4 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Parametric Portfolio Associates's 13F filing for Q4 2020, filed 12 Feb 2021.